Clinical Trials Logo

Reading Disabilities clinical trials

View clinical trials related to Reading Disabilities.

Filter by:
  • None
  • Page 1

NCT ID: NCT02680223 Completed - Vision Disorders Clinical Trials

Efficacy of Coloured Overlays and Lenses for Reading Difficulty

Start date: January 2016
Phase: N/A
Study type: Interventional

This is a randomised controlled trial with the aim of testing the efficacy of coloured overlays and coloured lenses for the relief of visual stress and reading difficulties in children and young adults.

NCT ID: NCT02607384 Completed - Refractive Error Clinical Trials

The Baltimore Reading and Eye Disease Study

BREDS
Start date: November 2014
Phase: N/A
Study type: Interventional

The Baltimore Reading and Eye Disease Study (BREDS) is a two year study to determine the prevalence of vision problems in an early school age population with reading difficulty. Comprehensive vision and reading tests will be administered to 400 students at participating schools in the Baltimore City Public School system. A secondary goal is to examine the impact of vision treatment on reading performance. Children with refractive error or convergence insufficiency will be provided treatment free of charge. The investigators will evaluate the impact that the treatment has on vision function and reading performance.

NCT ID: NCT02068261 Recruiting - Depression Clinical Trials

Working Memory Training in Adults With Substance Abuse and Executive Function Deficits.

Start date: January 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of a computerized working memory training program on substance abuse, psychosocial functioning, cognitive performance and psychiatric problems in adults with substance abuse and attention problems.

NCT ID: NCT01133847 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Interventions for Children With Attention and Reading Disorders

ICARD
Start date: November 2010
Phase: Phase 4
Study type: Interventional

The objective of this randomized clinical trial is to address unanswered questions about the relative effectiveness of treatments for children with both Attention Deficit Hyperactivity Disorder (ADHD) and significant reading difficulties (RD). The study evaluates attentional and word reading outcomes for students with both conditions when provided with either (a) ADHD treatment alone, (b) RD treatment alone, or (c) the combination of ADHD and RD treatment.

NCT ID: NCT00624234 Completed - Clinical trials for Neurofibromatosis Type 1

Neurobiology and Treatment of Reading Disability in NF-1

Start date: February 2006
Phase: N/A
Study type: Interventional

The goal of this trial is to determine if children with neurofibromatosis type 1 who have reading disabilities respond the same way-both behaviorally and neurobiologically-to specialized treatment programs as children with idiopathic reading disabilities do, and to determine which intervention is best for particular learner profiles.